X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (51) 51
humans (50) 50
male (39) 39
female (38) 38
adult (37) 37
infectious diseases (35) 35
hiv infections - drug therapy (32) 32
middle aged (29) 29
immunology (25) 25
double-blind method (24) 24
treatment outcome (24) 24
raltegravir (22) 22
aids/hiv (21) 21
aged (20) 20
raltegravir potassium (20) 20
adolescent (17) 17
drug therapy (17) 17
drug therapy, combination (16) 16
human immunodeficiency virus--hiv (16) 16
clinical trials (14) 14
hiv infections - virology (14) 14
hiv-1 - isolation & purification (14) 14
viral load (14) 14
antiretroviral drugs (13) 13
anti-hiv agents - administration & dosage (12) 12
anti-hiv agents - therapeutic use (12) 12
cd4 lymphocyte count (12) 12
hiv (12) 12
hiv-1 (12) 12
hiv-1 - drug effects (12) 12
microbiology (12) 12
pyrrolidinones - administration & dosage (12) 12
pharmacology & pharmacy (11) 11
rna, viral - blood (11) 11
aids (10) 10
anti-hiv agents - adverse effects (10) 10
beta-lactams (10) 10
efficacy (10) 10
infection (10) 10
pyrrolidinones - adverse effects (10) 10
drug administration schedule (9) 9
hiv infection (9) 9
integrase inhibitor (9) 9
penicillanic acid - analogs & derivatives (9) 9
safety (9) 9
virology (9) 9
abridged index medicus (8) 8
anti-bacterial agents - therapeutic use (8) 8
hiv integrase inhibitors - therapeutic use (8) 8
penicillanic acid - therapeutic use (8) 8
pharmacokinetics (8) 8
piperacillin - therapeutic use (8) 8
tenofovir (8) 8
efavirenz (7) 7
hiv infections - immunology (7) 7
hiv-1 - genetics (7) 7
lactams (7) 7
prospective studies (7) 7
pyrrolidinones - therapeutic use (7) 7
research (7) 7
therapy (7) 7
adenine - analogs & derivatives (6) 6
antiretroviral therapy (6) 6
article (6) 6
care and treatment (6) 6
dosage and administration (6) 6
hiv integrase inhibitors - administration & dosage (6) 6
integrase inhibitor raltegravir (6) 6
mk-0518 (6) 6
multicenter (6) 6
optimized background therapy (6) 6
treatment-experienced patients (6) 6
adults (5) 5
anti-bacterial agents - administration & dosage (5) 5
benzoxazines - administration & dosage (5) 5
benzoxazines - therapeutic use (5) 5
dose-response relationship, drug (5) 5
drug resistance (5) 5
drug resistance, viral (5) 5
emtricitabine (5) 5
ertapenem (5) 5
health aspects (5) 5
hiv integrase inhibitors - adverse effects (5) 5
hiv patients (5) 5
in-vitro activities (5) 5
mk-0826 (5) 5
organic chemicals - therapeutic use (5) 5
pelvic infection - microbiology (5) 5
protease inhibitors (5) 5
pyrrolidinones (5) 5
raltegravir potassium - therapeutic use (5) 5
startmrk (5) 5
young adult (5) 5
abdomen - microbiology (4) 4
adenine - administration & dosage (4) 4
adenine - therapeutic use (4) 4
administration, oral (4) 4
analysis (4) 4
anti-hiv agents - pharmacokinetics (4) 4
antiviral agents (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2013, Volume 13, Issue 7, pp. 587 - 596
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 05/2013, Volume 63, Issue 1, pp. 77 - 85
BACKGROUND:STARTMRK, a phase III noninferiority trial of raltegravir-based versus efavirenz-based therapy in treatment-naive patients, remained blinded until... 
raltegravir | HIV | STARTMRK | efavirenz | treatment naive | INFECTIOUS DISEASES | THERAPY | IMMUNOLOGY | HIV-1 INFECTION | SUBGROUP | Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination | HIV-1 | Oxazines | Humans | Male | Reverse Transcriptase Inhibitors - administration & dosage | Anti-HIV Agents - administration & dosage | Pyrrolidinones - administration & dosage | Reverse Transcriptase Inhibitors - adverse effects | Tenofovir | Deoxycytidine - therapeutic use | Adenine - adverse effects | Adenine - therapeutic use | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | Raltegravir Potassium | Emtricitabine | Pyrrolidinones - adverse effects | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Organophosphonates - therapeutic use | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | HIV Infections - virology | Organophosphonates - adverse effects | Pyrrolidinones - therapeutic use | Benzoxazines - adverse effects | Treatment Outcome | Adenine - administration & dosage | Benzoxazines - therapeutic use | Organophosphonates - administration & dosage | HIV Infections - drug therapy | Deoxycytidine - analogs & derivatives | Drug Combinations | Clinical trials | Patient safety | Antiretroviral drugs | Drug therapy | Comparative analysis | Human immunodeficiency virus--HIV | Index Medicus | AIDS/HIV | Indexing in process
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2008, Volume 359, Issue 4, pp. 339 - 354
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 09/2010, Volume 55, Issue 1, pp. 39 - 48
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 10/2011, Volume 53, Issue 8, pp. 807 - 816
Background. We compared 3 years of antiretroviral therapy with raltegravir or efavirenz as part of a combination regimen in the ongoing STARTMRK study of... 
HIV/AIDS | Antiretrovirals | Fasting | HIV | Body fat | Response rates | Viruses | Lipids | Fats | Virology | HIV 1 | INFECTIOUS DISEASES | RESISTANT HIV-1 INFECTION | MULTICENTER | EFFICACY | SAFETY | MICROBIOLOGY | HIV-1-INFECTED PATIENTS | RANDOMIZED CONTROLLED-TRIAL | IMMUNOLOGY | THERAPY | DOUBLE-BLIND | LOPINAVIR/RITONAVIR | SUBGROUP | Humans | Male | RNA, Viral - blood | Viral Load | Anti-HIV Agents - administration & dosage | Pyrrolidinones - administration & dosage | Tenofovir | Adenine - adverse effects | HIV-1 - isolation & purification | Adult | Deoxycytidine - adverse effects | Female | Drug Therapy, Combination | Raltegravir Potassium | Emtricitabine | Pyrrolidinones - adverse effects | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Drug Administration Schedule | HIV-1 - drug effects | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | HIV Infections - virology | Organophosphonates - adverse effects | Benzoxazines - adverse effects | Treatment Outcome | CD4 Lymphocyte Count | Absorptiometry, Photon | Adenine - administration & dosage | Organophosphonates - administration & dosage | Adolescent | HIV Infections - drug therapy | Deoxycytidine - analogs & derivatives | Usage | Drug utilization | HIV patients | Dosage and administration | Drug therapy, Combination | Drug therapy | Efavirenz | Raltegravir | Antiretroviral drugs | Ribonucleic acid--RNA | Human immunodeficiency virus--HIV | Cholesterol | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2008, Volume 359, Issue 4, pp. 355 - 365
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2004, Volume 351, Issue 14, pp. 1391 - 1402
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 2/2010, Volume 50, Issue 4, pp. 605 - 612
Journal Article
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 11/2009, Volume 52, Issue 3, pp. 350 - 356
Journal Article
Journal Article